Breaking News

LTS Acquires Sorrel Wearable Injection Device Business

The acquisition opens new opportunities for LTS to support pharma partners in the field of large molecules and biologics.

LTS Lohmann, a pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (TTS), Oral Thin Films (OTF) and Micro Array Patches (MAP), has acquired the Sorrel wearable injection device business headquartered in Netanya, Israel, a part of the Eitan Medical Ltd. In a statement, LTS Lohmann said that the acquisition is a crucial step in the company’s strategy to broaden its portfolio of drug delivery platforms. Sorrel’s larg...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters